Publications by authors named "Fangxin Hong"

Claim this Profile
E
Exploring Chemotherapy-Induced Peripheral Neuropathy Severity Patterns in Young Adult Women with Breast Cancer Receiving Weekly or Dose Dense Paclitaxel.
Robert Knoerl, Emanuele Mazzola, Lindsay Frazier, Roy L Freeman, Marilyn Hammer, Fangxin Hong

Eur J Cancer Care (Engl)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B.
Amy S Clark, Fangxin Hong, Richard S Finn, Angela M DeMichele, Edith P Mitchell

Clin Cancer Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trametinib in Patients With , , or -Mutant Tumors: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols S1 and S2.
Kari B Wisinski, Yael Flamand, Melissa A Wilson, Jason J Luke, Hussein A Tawbi, Fangxin Hong

JCO Precis Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring Clinicians' Perspectives of Barriers to Chemotherapy-Induced Peripheral Neuropathy Assessment and Management in Oncology Practice: A Qualitative Analysis of Semi-structured Interviews.
Robert Knoerl, Jessica Wallar, Erica Fox, Fangxin Hong, Elahe Salehi

Cancer Nurs· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials.
Sarah C Rutherford, Jun Yin, Levi Pederson, Gabriela Perez Burbano, Betsy LaPlant, Hongli Li, Fangxin Hong

J Clin Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How does patient-centered communication in ovarian cancer care enhance patient well-being? A mixed methods study.
Rachel A Pozzar, Niya Xiong, Fangxin Hong, Alexi A Wright, Barbara A Goff

Gynecol Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-Reported Severity, Characteristics, and Functional Limitations of Chemotherapy-Induced Peripheral Neuropathy.
Robert Knoerl, Emanuele Mazzola, Fangxin Hong, Elahe Salehi, Nadine McCleary

Pain Manag Nurs· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concordance between influential adverse treatment outcomes and localized prostate cancer treatment decisions.
Rachel A Pozzar, Niya Xiong, Fangxin Hong, Christopher P Filson, Peter Chang

BMC Med Inform Decis Mak· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Decision Support for Symptom Management in Lung Cancer Patients: A Group RCT.
Mary E Cooley, Emanuele Mazzola, Niya Xiong, Fangxin Hong, David F Lobach

J Pain Symptom Manage· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining allostatic load, neighborhood socioeconomic status, symptom burden and mortality in multiple myeloma patients.
Samilia Obeng-Gyasi, Noah Graham, Shaji Kumar, Ju-Whei Lee, Susanna Jacobus, Fangxin Hong

Blood Cancer J· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transitioning from heparin to saline locks for central venous access devices in oncology: An evidence-based practice approach.
Terri Jabaley, Niya Xiong, Susanne Conley, Teresa Mazeika, Danielle Johnson, Fangxin Hong

Can Oncol Nurs J· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Terri Jabaley, Niya Xiong, Susanne Conley, Teresa Mazeika, Danielle Johnson, Fangxin Hong

Can Oncol Nurs J· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Response Dynamics During First-Line Pembrolizumab Therapy in Patients With Advanced Non-Small-Cell Lung Cancer.
Mizuki Nishino, Fangxin Hong, Biagio Ricciuti, Hiroto Hatabu, Mark M Awad

JCO Precis Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silent mutations reveal therapeutic vulnerability in RAS Q61 cancers.
Yoshihisa Kobayashi, Chhayheng Chhoeu, Jiaqi Li, Kristin S Price, Lesli A Kiedrowski, Fangxin Hong

Nature· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Type I and Type II MET Tyrosine Kinase Inhibitors as Therapeutic Approach to Prevent Resistance.
Magda Bahcall, Cloud P Paweletz, Yanan Kuang, Luke J Taus, Taebo Sim, Fangxin Hong

Mol Cancer Ther· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knowledge and psychosocial impact of genetic counseling and multigene panel testing among individuals with ovarian cancer.
Rachel A Pozzar, Fangxin Hong, Niya Xiong, Jill E Stopfer, Manan M Nayak

Fam Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceived patient-centered communication, quality of life, and symptom burden in individuals with ovarian cancer.
Rachel A Pozzar, Niya Xiong, Fangxin Hong, Alexi A Wright, Barbara A Goff

Gynecol Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving beyond conventional stratified analysis to assess the treatment effect in a comparative oncology study.
Ryan Sun, Zachary McCaw, Lu Tian, Hajime Uno, Fangxin Hong

J Immunother Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement properties of brief neuropathy screening items in cancer patients receiving taxanes, platinums, or proteasome inhibitors.
Robert Knoerl, Emanuele Mazzola, Sandra A Mitchell, Fangxin Hong, Elahe Salehi

J Patient Rep Outcomes· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity.
Navin R Mahadevan, Erik H Knelson, Jacquelyn O Wolff, Amir Vajdi, Maria Saigí, Deli Hong, Fangxin Hong

Cancer Discov· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to What is a good medical choice?
Christopher P Filson, Fangxin Hong, Niya Xiong, Rachel Pozzar, Barbara Halpenny

Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412.
Grzegorz S Nowakowski, Fangxin Hong, David W Scott, William R Macon, Rebecca L King

J Clin Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPACEWALK: A Remote Participation Study of ALK Resistance Leveraging Plasma Cell-Free DNA Genotyping.
Marissa N Lawrence, Rubii M Tamen, Pablo Martinez, Alicia Sable-Hunt, Tony Addario, Fangxin Hong

JTO Clin Res Rep· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the impact of a decision support algorithm to improve clinicians' chemotherapy-induced peripheral neuropathy assessment and management practices: a two-phase, longitudinal study.
Robert Knoerl, Emanuele Mazzola, Fangxin Hong, Elahe Salehi, Nadine McCleary

BMC Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor: NCI-MATCH Subprotocol EAY131-Y Nonrandomized Trial.
Kevin Kalinsky, Fangxin Hong, Carolyn K McCourt, Jasgit C Sachdev, Edith P Mitchell

JAMA Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis